Doğan Çağatay, Gültekin Hamza M, Erdoğan Sarper M, Özkara Hamdi, Talat Zübeyr, Erözenci Ahmet N, Öbek Can
1 Istanbul University, Istanbul, Turkey.
Am J Mens Health. 2017 Jan;11(1):108-115. doi: 10.1177/1557988315599028. Epub 2016 Sep 21.
The current study assessed the decision-making process before surgery in prostate cancer patients. A structured telephone interview was conducted by an independent third party in 162 consecutive patients who underwent surgery for prostate cancer. Responders revealed that details regarding diagnosis and treatment alternatives were withheld from a significant number of patients. Radiation and active surveillance were presented as alternative options to surgery in 57 (39%) and 20 (14%) of responders, respectively. Twenty-six (18%) patients reported not being informed regarding potential surgical side effects. Patients were not active participants in critical aspects of decision making in 61 (42%) of the cases. Being inadequately informed and more frequent visits to the urologist appeared to make decisions more difficult. Treatment regret was reported by 23 (16%) of the patients who underwent surgery and was more common when the patient was not involved in the decision or was inadequately informed. As such, shared decision making should replace paternalism when managing patients with localized prostate cancer in urologic practice.
本研究评估了前列腺癌患者手术前的决策过程。由独立第三方对162例连续接受前列腺癌手术的患者进行了结构化电话访谈。受访者透露,相当多的患者未被告知诊断和治疗方案的详细信息。分别有57名(39%)和20名(14%)受访者被告知放疗和主动监测可作为手术的替代选择。26名(18%)患者报告未被告知潜在的手术副作用。在61例(42%)病例中,患者在决策的关键环节并非积极参与者。信息告知不足以及更频繁地就诊于泌尿科医生似乎使决策更加困难。23名(16%)接受手术的患者报告有治疗遗憾,当患者未参与决策或信息告知不足时更为常见。因此,在泌尿外科实践中管理局限性前列腺癌患者时,共同决策应取代家长式作风。